Trident TexofabBOM:540726 -4.23%63 EBITDA Margin % is -4.72% as of Mar. 2026. GuruFocus rates BOM:540726 with a GF Score™ of 63/100 and a GF Value™ of ₹63.42 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,039 Manufacturing - Apparel & Accessories companies, Trident Texofab ranks worse than 65.64% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Trident Texofab's EBITDA for the
three
months ended in Mar. 2026 was ₹-16 Mil. Trident Texofab's Revenue for the
three
months ended in Mar. 2026 was ₹336 Mil. Therefore, Trident Texofab's EBITDA margin for the quarter that ended in Mar. 2026 was -4.72%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Trident Texofab EBITDA Margin % Related Terms
Trident Texofab EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Trident Texofab's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Textile Manufacturing subindustry, Trident Texofab's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trident Texofab EBITDA Margin % vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Trident Texofab's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Trident Texofab's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trident Texofab (BOM:540726) has a EBITDA Margin % of -4.72% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Trident Texofab and its competitors. Over the past decade, Trident Texofab's EBITDA Margin % has ranged from 1.75 to 10.31. According to the industry distribution chart, Trident Texofab ranks #682 out of 1039 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 65.6%.
Is Trident Texofab's EBITDA Margin % too high?
Trident Texofab's current EBITDA Margin % is -4.72%. Over the past 10 years, this metric has ranged from a low of 1.75 to a high of 10.31. Based on the distribution chart, Trident Texofab ranks #682 out of 1039 companies in the Manufacturing - Apparel & Accessories industry, which is below the industry midpoint. Overall, Trident Texofab has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Texofab's EBITDA Margin % compare to competitors?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Trident Texofab ranks #682 out of 1039 companies for EBITDA Margin %. This places Trident Texofab in the lower half of its industry. The industry median EBITDA Margin % is 8.37. Historically, Trident Texofab's own EBITDA Margin % has ranged from 1.75 to 10.31 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Manufacturing - Apparel & Accessories company?
The median EBITDA Margin % among Manufacturing - Apparel & Accessories companies is 8.37, based on 1,039 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Trident Texofab and its competitors. For the Manufacturing - Apparel & Accessories industry, the median EBITDA Margin % is 8.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trident Texofab's current EBITDA Margin % is -4.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Texofab stock overvalued right now?
Based on GuruFocus' analysis, Trident Texofab (BOM:540726) is currently considered Possible Value Trap. The stock's GF Value™ is ₹63.42, compared to a current price of ₹36.00 — trading 43.2% below its estimated fair value. The current EBITDA Margin % is -4.72%. Trident Texofab's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Trident Texofab (BOM:540726), the current EBITDA Margin % is -4.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trident Texofab (BOM:540726) Overvalued in 2026?
Based on GuruFocus' analysis, Trident Texofab stock appears to be undervalued.
The current stock price of ₹36.00 is trading 43.2% below its estimated GF Value™ of ₹63.42.
GuruFocus considers Trident Texofab to be Possible Value Trap.
Key valuation signals for BOM:540726:
EBITDA Margin %: -4.72%
GF Value™: ₹63.42 vs. price of ₹36.00 (43.2% below fair value)
No single metric tells the full story. See the BOM:540726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trident Texofab Ltd is a multi-product fabric trading company. The company is engaged in the business of manufacturing & Wholesale Trading of Textile Fabric Cloth. Its brands are Storia Of Shed, Light Trail, Comfy Zoi, and Alicon. The company's products offering includes curtains, shower curtains, cushion covers, pillows and Bed sheets. It operates through the Textile Fabric Cloth segment.
63GF Score
Get the complete analysis for BOM:540726
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540726 has been successfully added to your 
